Unknown

Dataset Information

Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome.


ABSTRACT: Structural and numerical alterations of chromosome 21 are extremely common in hematological malignancies. While the functional impact of chimeric transcripts from fused chromosome 21 genes such as TEL-AML1, AML1-ETO, or FUS-ERG have been extensively studied, the role of gain of chromosome 21 remains largely unknown. Gain of chromosome 21 is a frequently occurring aberration in several types of acute leukemia and can be found in up to 35% of cases. Children with Down syndrome (DS), who harbor constitutive trisomy 21, highlight the link between gain of chromosome 21 and leukemogenesis, with an increased risk of developing acute leukemia compared with other children. Clinical outcomes for DS-associated leukemia have improved over the years through the development of uniform treatment protocol

SUBMITTER: Laurent AP 

PROVIDER: S-EPMC7387246 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature